Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Humanized anti-PSMA single-chain antibody and application thereof

A single-chain antibody, humanized technology, applied in the field of biomedicine, can solve problems such as immune damage, and achieve the effect of improving effectiveness, small molecular weight, and low immunogenicity

Pending Publication Date: 2019-11-05
JINLIN MEDICAL COLLEGE
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to provide a humanized anti-PSMA single-chain antibody, which solves the problem that animal-derived antibodies easily cause immune damage in the process of treating prostate cancer, and lays the foundation for targeted diagnosis and treatment of prostate cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Humanized anti-PSMA single-chain antibody and application thereof
  • Humanized anti-PSMA single-chain antibody and application thereof
  • Humanized anti-PSMA single-chain antibody and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Example 1: Enrichment and screening of phage library using PSMA antigen

[0016] 0.05mol / L carbonate buffer diluted PSMA recombinant protein to 10μg / mL antigen coating solution. Coat the immunotube with 1mL of antigen coating solution and store overnight at 4°C. The next day, the coating solution was discarded, 2.5% skimmed milk powder TBST solution was added, the immunotube was filled, and the tube was sealed at 37°C for 2 hours. After blocking, discard the blocking solution and rinse with PBST 10 times. Add 1 mL of the phage single-chain antibody library whose titer has been determined to the immunotube (the library capacity is about 10 11 CFU), incubated at 37°C for 2h. After the incubation of the antibody library, the phage antibody solution was aspirated and washed 10 times with PBST. Add 1 mL of 0.05 mol / L Gly-HCl solution to the immunotube and wait at room temperature for 5 minutes to elute the antigen-bound phages. Add 125 μL of 2 mol / L Tris solution to the ...

Embodiment 2

[0018] Example 2 Phage ELISA identification of scFv specificity

[0019] 30 clones were randomly selected from the plates after the fourth round of enrichment screening and cultured overnight. The next day, the strains were retained and re-activated by shaking. After the activated bacterial liquid grew to the logarithmic phase, the helper phage was infected, and the Kan resistance was supplemented overnight to induce the phage. The ELISA plate was coated with recombinant PSMA antigen overnight. The next day, the induced phage was used as the primary antibody, and the HRP-labeled anti-M13 antibody was used for ELISA detection.

[0020] Phage antibodies after the fourth round of enrichment were coated with PSMA recombinant protein on a 96-well plate, and the phage culture supernatant was screened by ELISA. A total of 30 clones were screened, and the positive standard was greater than 2 times the A value of the negative control. Among them, 3 clones were positive, and the posi...

Embodiment 3

[0021] Example 3 Determination of Nucleic Acid Sequence and Homology Analysis.

[0022] The above three positive clones were sequenced by Suzhou Jinweizhi Company after amplification of antibody variable region genes. Homology comparisons were performed using the Nucleotide Blast analysis software in NCBI. The results show:

[0023] The heavy chain nucleotide sequence is 94.68% homologous to the human immunoglobulin heavy chain variable region nucleotide sequence,

[0024]

[0025] The light chain nucleotide sequence is 97.22% homologous to the human immunoglobulin light chain nucleotide sequence.

[0026]

[0027]The sequencing results of the three positive clones showed that the nucleic acid sequences were basically identical. The nucleotide sequence encoding the heavy chain is shown in SEQ ID NO.1, and the nucleotide sequence encoding the light chain is shown in SEQ ID NO.2.

[0028] Homology comparisons were performed using the Nucleotide Blast analysis software ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a humanized anti-PSMA single-chain antibody, which includes a heavy chain and a light chain which are connected with a linker. The nucleotide sequence of the heavy chain is coded as SEQ ID NO.1, and the nucleotide sequence of the light chain is coded as SEQ ID NO.2. An effective antibody preparation is provided for diagnosis, treatment and prognosis of prostate cancer. Compared with a PSMA murine monoclonal antibody in the prior art, the humanized anti-PSMA single-chain antibody has a different source, and the toxic and side effects of a heterologous antibody on a human body is avoided.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and specifically relates to a humanized anti-prostate specific membrane antigen (prostate specific membrane antigen, PSMA) single-chain antibody and its application in the treatment and diagnosis of prostate cancer. Background technique [0002] Single-chain antibody is a new type of genetically engineered antibody, which is formed by linking the variable region of the heavy chain and the variable region of the light chain of the antibody through a short peptide. Its advantages are: (1) The size of the single-chain antibody is only that of a complete antibody (2) The molecular weight of the single-chain antibody is small, its immunogenicity is lower, the half-life is shorter, and it is easier to penetrate the tumor tissue and reach the boot site; (3) ) Since the single-chain antibody lacks the Fc segment of the complete antibody, it is not easy to bind to target cells containing Fc receptors,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/30G01N33/574A61K39/395A61P35/00
CPCC07K16/3069G01N33/57434A61P35/00C07K2317/24C07K2317/50A61K2039/505
Inventor 王立国蔡建辉方芳李强朱文赫王艳春于航张铎
Owner JINLIN MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com